GELTEQ LIMITED ORDINARY SHARES (NASDAQ: GELS)

NASDAQ: GELS (Gelteq Limited)

最近更新时间: 20小时之前

-0.96 (-25.26%)

加入群组

股市价格/股市净资产 (P/B)

3.67

52周波幅

1.42 (-50%) — 4.98 (75%)

市场趋势

		短期	中期
行业	Drug Manufacturers - Specialty & Generic (US)	看跌	看涨
	Drug Manufacturers - Specialty & Generic (全球的)	混合的	混合的
股票	Gelteq Limited	-	-

AIStockmoo 评分

-1.5

相关股票

股票	市值	DY	P/E（TTM）	P/B
GELS	27 M	-	-	3.67
CTOR	67 M	-	-	3.33
CANB	4 M	-	-	33.49
SHPH	3 M	-	-	4.16
ACORQ	186 K	-	-	-
NEPTF	91 K	-	-	0.560

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
部门	Healthcare
行业	Drug Manufacturers - Specialty & Generic
内部持股比例	65.03%

该时间范围内无数据。

日期	类型	细节
02 Dec 2024	公告	Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
26 Nov 2024	公告	Gelteq Announces 400,000 Units Enter into Production in November 2024
12 Nov 2024	公告	Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
30 Oct 2024	公告	Gelteq Limited Closes US$5.2 Million Initial Public Offering
28 Oct 2024	公告	Gelteq Limited Prices US$5.2 Million Initial Public Offering

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

没有符合您标准的股票

资产报酬率 (ROA TTM)	-7.43%
股东权益报酬率 (ROE TTM)	-18.75%